132 related articles for article (PubMed ID: 31842811)
1. Vaginal dose of radical radiotherapy for cervical cancer in China: a multicenter study.
Wang J; Zhang KS; Wang T; Liu Z; Wang RH; Zhang FQ; Yu L; Ran L; He JL; Wang YL; Wei LC; Shi M; Wang GQ; Wu CQ; Kang QJ; Yang J; Li S; Yang FY; Liu BG; Liu JY; Shi F; Su J; Yuan W; Drokow EK
BMC Cancer; 2019 Dec; 19(1):1219. PubMed ID: 31842811
[TBL] [Abstract][Full Text] [Related]
2. Using New Vaginal Doses Evaluation System to Assess the Dose-Effect Relationship for Vaginal Stenosis After Definitive Radio(Chemo)Therapy for Cervical Cancer.
Wang J; Zhang KS; Liu Z; Wang T; Wang RH; Zhang FQ; Yu L; Wang YL; Wei LC; Shi M; Li S; Liu BG; Shi F; Su J; Yuan W; Zhang QY; Zhang J
Front Oncol; 2022; 12():840144. PubMed ID: 35515128
[TBL] [Abstract][Full Text] [Related]
3. Assessment of dose to functional sub-structures in the lower urinary tract in locally advanced cervical cancer radiotherapy.
Spampinato S; Fokdal L; Marinovskij E; Axelsen S; Pedersen EM; Pötter R; Lindegaard JC; Tanderup K
Phys Med; 2019 Mar; 59():127-132. PubMed ID: 30772142
[TBL] [Abstract][Full Text] [Related]
4. Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study.
Westerveld H; Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Spampinato S; Sturdza A; Nesvacil N; Bruheim K; Hellebust TP; Pieters BR; Kirisits C; Jürgenliemk-Schulz IM; Pötter R; de Leeuw AAC
Radiother Oncol; 2022 Mar; 168():8-15. PubMed ID: 35063582
[TBL] [Abstract][Full Text] [Related]
5. Vaginal dose assessment in image-guided brachytherapy for cervical cancer: Can we really rely on dose-point evaluation?
Limkin EJ; Dumas I; Rivin Del Campo E; Chargari C; Maroun P; Annède P; Petit C; Seisen T; Doyeux K; Tailleur A; Martinetti F; Lefkopoulos D; Haie-Meder C; Mazeron R
Brachytherapy; 2016; 15(2):169-76. PubMed ID: 26778755
[TBL] [Abstract][Full Text] [Related]
6. Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients.
Westerveld H; de Leeuw A; Kirchheiner K; Dankulchai P; Oosterveld B; Oinam A; Hudej R; Swamidas J; Lindegaard J; Tanderup K; Pötter R; Kirisits C;
Radiother Oncol; 2016 Sep; 120(3):420-427. PubMed ID: 27237058
[TBL] [Abstract][Full Text] [Related]
7. Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy.
Westerveld H; Pötter R; Berger D; Dankulchai P; Dörr W; Sora MC; Pötter-Lang S; Kirisits C
Radiother Oncol; 2013 Apr; 107(1):99-105. PubMed ID: 23639578
[TBL] [Abstract][Full Text] [Related]
8. Dose at posterior-inferior border of symphysis point: A predictor for vaginal stricture in cervical cancer.
Singh A; Mani N; Aggarwal LM; Agarwal S; Mourya A; Verma A; Bagchi A; Gupta N; Choudhary S
Brachytherapy; 2023; 22(5):616-622. PubMed ID: 37286402
[TBL] [Abstract][Full Text] [Related]
9. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
[TBL] [Abstract][Full Text] [Related]
10. Comparison of dose delivered to vagina using two different intracavitary brachytherapy applicators for carcinoma cervix.
Bajwa HK; Talluri AK; Maqbool A; Reddy D; Singareddy R; Sresty NM; Raju AK
Brachytherapy; 2022; 21(2):151-157. PubMed ID: 34756698
[TBL] [Abstract][Full Text] [Related]
11. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
12. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
Cheng JC; Peng LC; Chen YH; Huang DY; Wu JK; Jian JJ
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1010-8. PubMed ID: 14575832
[TBL] [Abstract][Full Text] [Related]
13. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
14. Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator position.
Nkiwane KS; Pötter R; Fokdal LU; Hoskin P; Pearcey R; Segedin B; Mahantshetty U; Kirisits C
Brachytherapy; 2015; 14(2):252-9. PubMed ID: 25530424
[TBL] [Abstract][Full Text] [Related]
15. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
16. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
[TBL] [Abstract][Full Text] [Related]
17. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
Kirchheiner K; Nout RA; Lindegaard JC; Haie-Meder C; Mahantshetty U; Segedin B; Jürgenliemk-Schulz IM; Hoskin PJ; Rai B; Dörr W; Kirisits C; Bentzen SM; Pötter R; Tanderup K;
Radiother Oncol; 2016 Jan; 118(1):160-6. PubMed ID: 26780997
[TBL] [Abstract][Full Text] [Related]
18. A comparison of ICRU point doses and volumetric doses of organs at risk (OARs) in brachytherapy for cervical cancer.
Vinod SK; Caldwell K; Lau A; Fowler AR
J Med Imaging Radiat Oncol; 2011 Jun; 55(3):304-10. PubMed ID: 21696566
[TBL] [Abstract][Full Text] [Related]
19. Vaginal 11-point and volumetric dose related to late vaginal complications in patients with cervical cancer treated with external beam radiotherapy and image-guided adaptive brachytherapy.
Dankulchai P; Harn-Utairasmee P; Prasartseree T; Nakkasae P; Trikhirhisthit K; Sittiwong W; Thephamongkhol K; Petsuksiri J; Apiwarodom N; Iampongpaiboon P; Chansilpa Y
Radiother Oncol; 2022 Sep; 174():77-86. PubMed ID: 35839936
[TBL] [Abstract][Full Text] [Related]
20. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
